CMDS is a population-based analytical tool for identifying recurrent DNA copy number aberration in multiple samples. It was developed for efficient analysis of high resolution and large population data. It doesn't require single-sample calling and can be directly applied to raw intensity (or intensity ratio) data from SNP chips or read count data from sequencing. CMDS has been successfully applied to the Tumor Sequencing Project (TSP) and The Cancer Genome Atlas (TCGA) data.
CMDS has been requested/used worldwide by researchers from such as Hamamatsu University School of Medicine (Japan), Beijing Institute of Genomics (China), The Arthur and Sonia Labatt Brain Tumor Research Centre (Canada), Nutrigenetics Unlimited, Inc. (USA), Baylor College of Medicine's Human Genome Sequencing Center (USA).